↓ Skip to main content

Alemtuzumab as rescue therapy in a cohort of 50 relapsing–remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study

Overview of attention for article published in Journal of Neurology, April 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
12 X users
facebook
1 Facebook page

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
74 Mendeley